(Press-News.org) Boston – Researchers at Dana-Farber Brigham Cancer Center have found that a shorter course of radiation therapy after mastectomy and breast reconstruction surgery provides the same protection against breast cancer recurrence and equivalent physical side-effects but substantially reduces life disruption and financial burden for patients.
The results of the multicenter randomized clinical trial – the FABREC Study (Hypofractionated versus Conventionally Fractionated Postmastectomy Radiation Therapy After Implant-Based Reconstruction) – were presented at the American Society for Radiation Oncology (ASTRO) annual meeting in San Diego, CA, on October 1, 2023, and will be featured in a news briefing.
Hypofractionated radiation therapy provides a higher dose of radiation in each session and is completed in three weeks while conventional radiation therapy delivers a lower dose over five weeks. This is the first randomized trial comparing a three-week course of radiation therapy to a five-week course in patients with breast cancer who have had a mastectomy with immediate reconstruction.
“Our trial results suggest that hypofractionation can safely be used in this setting without compromising efficacy or increasing side effects,” says senior author Rinaa S. Punglia, MD, MPH, a radiation oncologist at Dana-Farber Brigham Cancer Center. “Reducing the requirement to three weeks of radiation therapy would be a significant improvement in the quality of our patients’ lives.”
Many patients with breast cancer opt for a mastectomy to reduce the chances of cancer recurrence. For one in three of these patients, postmastectomy radiation therapy is recommended to further reduce the chance of recurrence.
More and more women opt for implant-based reconstruction to be done as part of the mastectomy. However, radiation therapy increases the risk of complications with the breast reconstruction, including an increased risk of infection, and cosmetic risks such as the formation of scar tissue around the breast that causes hardness and asymmetry.
“We know that radiation can cause unwanted changes to cosmetic results in patients who have mastectomy and reconstruction,” says first author Julia S. Wong, MD, a radiation oncologist at Dana-Farber Brigham Cancer Center. “With this trial we were looking for a way to improve quality of life and cosmetic results without sacrificing efficacy.”
To compare the short and long courses of radiation therapy in the mastectomy setting, the investigators recruited 400 patients with stage 0 to III breast cancer who were treated with mastectomy and immediate implant-based radiation and who required post-surgical radiation therapy. They followed the patients for a median of 40 months to track recurrence and radiation related side effects.
They also evaluated patient-reported outcomes, including physical wellbeing, using the FACT-B patient reporting tool six months after radiation treatment. The tool asks patients to gauge how they feel physically, emotionally, socially, and functionally and reports a composite score.
Oncologic outcomes were very similar between the two groups, with comparable numbers of patients experiencing recurrence after a median of 40 months of follow-up. Radiation related side-effects were also similar.
The patient-reported improvement in physical well-being assessment, the study’s primary endpoint, was also similar between the two treatment groups, suggesting that the shorter course of treatment did not lead to a larger improvement in quality of life. Among patients younger than 45, there was a small but statistically significant benefit in physical well-being for those who received the short course radiation therapy at the 6-month timepoint.
The shorter course of radiation therapy did, however, reduce the burden on patients’ time and finances.
“The difference between three weeks and five weeks presents a significant improvement in the quality of our patients’ lives in terms of the disruption of their work, family, social, and financial lives,” says Wong.
For example, among those patients in the study who took unpaid time off from work for treatment, those undergoing the short course of radiation therapy required 73.7 hours of unpaid leave, while those undergoing the longer course required 125.8 hours. In previous surveys, patients receiving a five-week course of radiation therapy have noted the burden of the schedule on their time and finances.
Further, fewer patients receiving the shorter course of radiation therapy missed a day of therapy. Interruptions in radiation can lead to worse outcomes.
“These patients have already had so much treatment, including chemotherapy and a lot of surgery,” says Punglia. “They underscored for us in survey responses how onerous it was for them to have five weeks of treatment.”
In future studies, the team will continue to explore even shorter courses of radiation therapy and novel forms of radiation therapy in a continued effort to reduce the burden of treatment without compromising efficacy.
This research was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (CER-1609-36063).
Punglia will discuss the FABREC study (LBA 05) in an ASTRO news briefing at the San Diego Convention Center and via live webcast. The briefing is scheduled for Monday, October 2nd, 2:00-3:00pm ET. More information at www.astro.org/annualmeetingpress.
About Dana Farber Brigham Cancer Center:
Dana-Farber Brigham Cancer Center brings together specialists from two world-class medical centers. Physicians from both hospitals bring deep experience in treating various cancers and the care teams include experts from a wide span of disciplines, such as medical and radiation oncologists, cancer surgeons and many others. We offer access to the latest treatments, many of which were pioneered at Dana-Farber Brigham Cancer Center, along with clinical trials for promising new therapies.
####
END
SAN DIEGO, October 1, 2023 — In a first-of-its-kind study, people with breast cancer who underwent implant-based breast reconstruction immediately following a mastectomy reported that getting fewer, higher doses of radiation was just as effective as standard radiation, did not increase side effects and saved them time and money. There also was a small improvement in quality of life for women under 45 who received the shortened treatment regimen.
The FABREC study is the first prospective randomized study comparing quality-of-life and clinical outcomes following accelerated versus conventional radiation therapy specifically for patients with ...
SAN DIEGO, October 1, 2023 — People who engage in sexual activity or vaginal dilation after chemoradiation treatment for cervical cancer are at lower risk for long-term side effects, according to a new study from researchers in Austria. Findings of the EMBRACE study will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
“Curing cancer is always our first priority,” said lead study author Kathrin Kirchheiner, MSc, PhD, a clinical psychologist in the department of radiation oncology at the Medical University of Vienna. “But with a growing number of relatively young cervical cancer survivors, ...
SAN DIEGO, October 1, 2023 — Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted, high-dose radiation, a new study from Australian and Dutch researchers suggests.
A multi-institutional phase II study – TransTasman Radiation Oncology Group (TROG) FASTRACK II – found 100% local control and cancer-specific survival for longer than three years among patients who were treated non-invasively for inoperable kidney cancer with stereotactic ablative body radiotherapy (SABR). Findings will be presented today at the American Society for Radiation Oncology (ASTRO) ...
SAN DIEGO, October 1, 2023 — Two liquid biopsy tests that look for the presence of human papillomavirus (HPV) in the blood accurately identified patients with a high risk of cervical cancer recurrence after the completion of chemoradiation, a new study confirms. Findings will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
The study compared two novel tests – a digital polymerase chain reaction (dPCR) test and a sequencing test for genetic material from HPV, the main cause of cervical cancer – and found they were equally effective at identifying residual disease in the blood of patients who ...
New Haven, Conn. — In a common metaphor used to describe human fertilization, sperm cells are competitors racing to penetrate a passive egg. But as critics have noted, the description is also a “fairy tale,” rooted in cultural beliefs about masculinity and femininity.
A new study by Yale sociologist Rene Almeling provides evidence that this metaphor remains widely used despite the profound shift in recent decades in social and scientific views about gender, sex, and sexuality. But her findings, based ...
New research to be presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 October) and published in the journal Diabetes Therapy suggests that the diagnosis threshold for type 2 diabetes (T2D) should be lowered in women aged under 50 years, since natural blood loss through menstruation could be affecting their blood sugar management. The study is by Dr Adrian Heald, Salford Royal Hospital, UK, and colleagues.
Analysis of the national diabetes ...
Anion exchange membrane fuel cells (AEMFCs) have gained attention in the process of fuel cell development because they operate in alkaline environments, the redox reaction rate at the electrodes is faster, and non-precious metal catalysts such as Ni, Co, and Ag can be used, which reduces the cost of fuel cells. However, the mobility of OH- is only 56.97% of that of H+ under the same conditions, and its stability is poor, so improving the ionic conductivity and mechanical properties of anion exchange membranes (AEM) is the key to the commercialization ...
Tokyo, Japan – Scientists from Tokyo Metropolitan University have realized a new polymer that can effectively transport plasmid DNA into T-cells during chimeric antigen receptor (CAR) T-cell therapy, a key treatment for blood cancer. Importantly, it can get genes into floating T-cells, not only ones fixed to surfaces. It is stable, non-toxic, and doesn’t use viruses. It outperforms polyion compounds considered a gold standard in the field, paving the way for new therapies.
T-cells, or lymphocytes, are a type of white blood cell that helps our immune system fight germs and protect us from disease. Recently, technology has become available that helps reprogram T-cells to fight cancer. ...
(Santa Barbara, Calif.) — Sometimes simple solutions are better. It all depends on the nature of the problem. For humpback whales, the problem is the rope connecting a crab trap on the seafloor to the buoy on the surface. And for fishermen, it’s fishery closures caused by whale entanglements.
Managing this issue is currently a major item on California’s agenda, and it appears less fishing gear may be the optimal solution. So says a team of researchers led by Christopher Free, at UC Santa Barbara, after modeling the benefits and impacts that several management strategies would have on whales and fishermen. ...
A virtual reality (VR) game crashes. A robot rolls dangerously close to the edge of a cliff. An autonomous vehicle speeds toward a pedestrian. Without intelligent control happening every millisecond, accidents can occur. This control can mean applying the brake of an autonomous vehicle to save a life or creating a more user-friendly augmented reality experience.
Two professors in the Department of Electrical and Computer Engineering at Texas A&M University are working to enhance and advance the future ...
